130 related articles for article (PubMed ID: 34694951)
1. Perceptions and knowledge gaps on CHA
Zhang C; Shen L; Pan MM; Zheng YL; Gu ZC; Lin HW
Postgrad Med; 2022 Jan; 134(1):64-77. PubMed ID: 34694951
[TBL] [Abstract][Full Text] [Related]
2. The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke.
Zhang J; Lenarczyk R; Marin F; Malaczynska-Rajpold K; Kosiuk J; Doehner W; Van Gelder IC; Lee G; Hendriks JM; Lip GYH; Potpara TS
Europace; 2021 Feb; 23(2):314-322. PubMed ID: 33554259
[TBL] [Abstract][Full Text] [Related]
3. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
[TBL] [Abstract][Full Text] [Related]
4. Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment.
Heidbuchel H; Dagres N; Antz M; Kuck KH; Lazure P; Murray S; Carrera C; Hindricks G; Vahanian A
Europace; 2018 Dec; 20(12):1919-1928. PubMed ID: 29538637
[TBL] [Abstract][Full Text] [Related]
5. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
[TBL] [Abstract][Full Text] [Related]
6. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
7. Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients.
Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
Europace; 2014 Feb; 16(2):195-201. PubMed ID: 24036378
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?
Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Heart Rhythm; 2016 Jan; 13(1):46-53. PubMed ID: 26277496
[TBL] [Abstract][Full Text] [Related]
9. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
10. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex).
Xie X; Li T
Acta Cardiol; 2021 May; 76(3):258-264. PubMed ID: 32056508
[TBL] [Abstract][Full Text] [Related]
12. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
13. CHA
Harb SC; Wang TKM; Nemer D; Wu Y; Cho L; Menon V; Wazni O; Cremer PC; Jaber W
Open Heart; 2021 Nov; 8(2):. PubMed ID: 34815301
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
Dupree L; DeLosSantos M; Smotherman C
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
[TBL] [Abstract][Full Text] [Related]
15. Relationship among atrial fibrillation, the CHA
Shi B; Liu D; Wang Q; Geng X; Hou Q; Gu G; Xie R; Cui W
BMC Cardiovasc Disord; 2021 Oct; 21(1):474. PubMed ID: 34600490
[TBL] [Abstract][Full Text] [Related]
16. The Value of the CHADS
Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449
[TBL] [Abstract][Full Text] [Related]
17. Stroke Risk in Atrial Fibrillation: Beyond the CHA
Jagadish PS; Kabra R
Curr Cardiol Rep; 2019 Jul; 21(9):95. PubMed ID: 31352536
[TBL] [Abstract][Full Text] [Related]
18. [The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].
Liu XB; Jia ZX; Xia SJ; He L; Lu SX; Guo XY; Li SN; Liu N; Jiang CX; Sang CH; Tang RB; Long DY; Yu RH; Bai R; Wu JH; Du X; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):735-739. PubMed ID: 32957755
[No Abstract] [Full Text] [Related]
19. Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.
van den Ham HA; Klungel OH; Singer DE; Leufkens HG; van Staa TP
J Am Coll Cardiol; 2015 Oct; 66(17):1851-9. PubMed ID: 26493655
[TBL] [Abstract][Full Text] [Related]
20. [Impacts of radiofrequency ablation on quality of life of atrial fibrillation patients with low CHA2DS2-VASc score].
Bai Y; Liu N; Bai R; Wu JH; Shi XB; Liu XY; Liu XH; Du X; Dong JZ; Ma CS
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):278-82. PubMed ID: 27030615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
